Sagent Pharmaceuticals Launches Oxacillin for Injection

Sagent Pharmaceuticals announced the launch of Oxacillin for Injection, USP, in three latex-free, preservative-free vial presentations.

Oxacillin features the company's PreventIV Measures packaging and labeling designed to aid in the reduction of medication errors.

Oxacillin for Injection, USP is a semisynthetic penicillin indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug.

For more information call (866) 625-1618 or visit www.sagentpharma.com.